Radioactive glass beads aim to destroy kidney tumors without surgery

NCT ID NCT06432036

Recruiting now Disease control Sponsor: Jonsson Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study tests a treatment called radioembolization for early-stage kidney cancer. Tiny glass beads containing radioactive yttrium-90 are injected into the artery feeding the tumor to kill cancer cells from inside. The goal is to see if this approach is safe and effective for 25 adults with stage I or II kidney cancer who are not eligible for or want to avoid surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I RENAL CELL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UCLA / Jonsson Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90095, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

STAGE I RENAL CELL CANCER STAGE I RENAL CELL CANCER STAGE II RENAL CELL CANCER STAGE II RENAL CELL CANCER